Kurome Therapeutics: Funding, Investors & Team (Aug 2026)
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that target cancer cells that have co-opted immune signaling pathways to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
Kurome Therapeutics has raised $15.0M across 1 funding round on record, the most recent an undisclosed round of $15.0M announced in Jun 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kurome Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Kurome Therapeutics Funding Rounds
Kurome Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Kurome Therapeutics Funding Compared to Other Biotechnology Startups
Kurome Therapeutics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kurome Therapeutics in Biotechnology and Cincinnati
Companies Similar to Kurome Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Kurome Therapeutics Funding FAQs
What does Kurome Therapeutics do?
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that target cancer cells that have co-opted immune signaling pathways to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
How much funding has Kurome Therapeutics raised?
Kurome Therapeutics has raised $15.0M across 1 round on record. The most recent is an undisclosed round of $15.0M announced in Jun 2021.
When did Kurome Therapeutics last raise funding?
Kurome Therapeutics' most recent funding round on record is an undisclosed round of $15.0M, announced in Jun 2021.
Who is the CEO of Kurome Therapeutics?
Jan Rosenbaum is listed as CEO at Kurome Therapeutics.
Where is Kurome Therapeutics headquartered?
Kurome Therapeutics is based in Cincinnati, Ohio, United States.
How many employees does Kurome Therapeutics have?
Kurome Therapeutics is in the 1-10 employee band.
How does Kurome Therapeutics' funding compare to other Biotechnology startups?
Kurome Therapeutics' latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Kurome Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kurome Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.